The urgent need for treatment doesn’t end when a person regains a pulse after suffering sudden cardiac arrest — healthcare providers need to move quickly into post-cardiac arrest care to keep a person alive and ensure the best outcome.
That’s the conclusion of the American Heart Association science advisory published in Circulation: Journal of the American Heart Association.
Brain injury, heart dysfunction, systemic inflammation and the underlying disease that caused the cardiac arrest all contribute to the high death rate of patients who initially have their pulse re-started. Collectively, these symptoms are known as post-cardiac arrest syndrome.
The largest modern report of cardiac arrest resuscitation was published by the National Registry of CPR in 2006. Among the 19,819 adults and 524 children whose hearts were re-started, in-hospital mortality rates were 67 percent and 55 percent, respectively.
The new statement says there is growing evidence that post-cardiac arrest care can lower the death rate and improve functional outcome for these patients.
“Although we have become better at restarting the heart, we are only beginning to learn and implement the best ways to keep patients alive and minimize brain damage after their heart is re-started,” said Robert W. Neumar, M.D., Ph.D., head of the statement writing committee and associate professor of emergency medicine and associate director of the Center for Resuscitation Science at the University of Pennsylvania in Philadelphia.
Research shows that many aspects of post cardiac arrest syndrome can be treated. The advisory discussed treatments for various types of patients such as:
The advisory also discussed treatment for high blood sugar, seizures and infection, all of which are common concerns after cardiac arrest resuscitation. Also, inserting an implantable cardioverter defibrillator (ICD) is indicated for many patients with good neurological function.
Statement co-authors include: Co-chair; Jerry P. Nolan, FRCA, FCEM, co-chair; Christophe Adrie, M.D., Ph.D.; Mayuki Aibiki, M.D., Ph.D.; Bernd W. Böttiger, M.D.; Robert A. Berg, M.D.; Clifton Callaway, M.D., Ph.D.; Robert S. B. Clark, M.D.; Romergryko G. Geocadin, M.D.; Edward C. Jauch, M.D.; Karl B. Kern, M.D.; Ivan Laurent, M.D.; W.T. Longstreth Jr, M.D., M.P.H.; Laurie J. Morrison, M.D.; Peter Morley, MBBS, FRACP; Raina M. Merchant, M.D.; Vinay Nadkarni, M.D.; Mary Ann Peberdy, M.D.; Antonio Rodriguez-Nunez, M.D., Ph.D.; Emanuel P. Rivers, M.D.; Christian Spaulding, M.D.; Frank W. Sellke, M.D.; Kjetil Sunde, M.D., Ph.D.; Terry Vanden Hoek, M.D.
Cite This Page: